美纳里尼新闻专区

Our site uses cookies to make navigation as function as possible, including “third party” cookies and “profiling cookies” designed to tailor
on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your
consent to some or all cookies, click here. If you proceed with browsing this website, you will be consenting to the use of all cookies.

美纳里尼新闻专区

2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011

2022

Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingJune 06 2022

2021

2020

2019

Tillotts制药公司与美纳里尼达成合作：将Asacol®药物引入中国October 08 2019
MENARINI: ELCIN BARKER ERGUN GROUP CEOSeptember 12 2019
Dermatix(R) Unveils New Product Breakthrough for Acne Scarring SolutionJuly 23 2019
CALECIM® partners Menarini Asia-Pacific to expand reach of its stem cell skin care products in the regionMay 01 2019

2018

Menarini Increases Number Of Members Of The Board – For The First Time External Members In MajorityNovember 07 2018
Two-thirds of Australians surveyed affected by mild anxiety1October 16 2018
Menarini and Orion Sign Regional Partnerships in Asia-PacificJuly 03 2018
Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for Commercializing LIXIANA® in the Philippines, Malaysia and SingaporeJune 29 2018
Menarini Announces New GovernanceMarch 22 2018
Menarini Hires Their 17,000th EmployeeMarch 12 2018

2017

意大利警察CSI部门使用新技术打击犯罪September 28 2017
COPD: 增加患者和医生之间的开放式对话September 11 2017
Menarini Increases Number Of Members Of The Board – For The First Time External Members In MajorityJune 29 2017
Selvita And Menarini Group announce Global License Agreement for Clinical Stage Oncology Drug PimFlt3 Inhibitor Sel24June 29 2017
Menarini arrives in Columbia and PeruMarch 13 2017
Melinta Therapeutics and Menarini Group Enter into Commercial and Co-Development Agreement for Delafloxacin in 68 CountriesMarch 03 2017
Menarini in Turkey: + 25% Growth in 2016 and New Headquarters in IstanbulJanuary 19 2017

2016

Menarini Acquires CELLSEARCH Business from American Group Janssen Diagnostics, Pioneer in High-tech Cancer DiagnosticsDecember 21 2016
美纳里尼集团：10 个月新增 250 名员工December 06 2016
反虐待未成年者的儿科网络October 19 2016
美纳里尼集团和默沙东的全球伙伴关系扩展到亚太地区June 09 2016
英维达（Invida）出席生物技术行业大会中的生物世纪未来领袖（BioCentury Future Leaders）论坛May 11 2016
美纳里尼宣布与 BIOSYNTH 合资成立 VAXYNETHICMarch 16 2016
田边三菱制药株式会社与美纳里尼亚太公司签署Spedra (Avanafil)在亚太区十个国家和地区的授权协议February 26 2016

2015

4SC 与 Menarini 签署 Resminostat 在日本以外的亚太区的许可和开发协议March 16 2015

2014

美纳里尼集团：治疗淋巴瘤和实体瘤的新型分子November 25 2014
美纳里尼十大最贴近患者需求的公司公司之一June 20 2014
三位访问专家强烈建议女性促其伴侣接受早泄治疗March 07 2014
Moberg Pharma 与美纳里尼签署 Kerasal Nail™ 在东南亚的扩展分销协议February 14 2014

2013

2012

2011

如需了解更多关于美纳里尼的信息，请点击此处下载查阅 PDF 文件。.

美纳里尼基金会

该基金会成立于 1976 年...

美纳里尼在亚太地区

搜索我们的公司

选择您的市场:

主要品牌

专题文章

Daiichi Sankyo and Menarini Enter into Exclusive Licensing Agreement for Commercializing LIXIANA® in the Philippines, Malaysia and Singapore